Abstract
Bioresorbable polymer microparticles are widely used to provide long-lasting drug delivery in several chronic diseases. Having fine control over the physical properties of such microparticles can improve product reproducibility, performance and process efficiency. By using an ink-jet based droplet generator device, a new approach to microparticle manufacture was explored that uses an extremely rapid phase-separation to produce highly uniform, injectable microparticles from PLGA and a PLA/PLGA blend. To demonstrate the possible pharmaceutical applicability of the microparticle printing technique, the approved peptides ciclosporin A and octreotide were formulated, producing low-density microparticles that showed between sustained release over several months. The facile scale-up of the technique was demonstrated by using an array of 256 ink-jet nozzles, allowing over 1million discrete particles per second to be produced. The new apparatus and methods described herein could be used across a wide range of biomaterials and therapeutic compounds.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
